(MBPL) is a pharmaceutical company that manufactures pharmaceutical products like tablets and capsules. The company intends to manufacture vaccines and biologics by implementing international best practices. This is one of the few pharmaceutical companies in Nepal that is owned and managed by people with medical degrees with extensive local and international experience in the sector.
MBPL has signed a technology transfer agreement (TTA) with Korean bio-pharmaceutical company, Eubiologics, which is a South Korean bio-pharmaceutical company that engages in developing new vaccine for new epidemics and antibiotic resistance. MBPL is one of the first companies to have a TTA with a reputed foreign pharmaceutical company in Nepal.
Bo2 investments will help scale up their operations.